Clinical Trial Update: Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating intralesional 5-fluorouracil and topical calcipotriene for squamous cell carcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Calcipotriene (calcipotriene)

Snippet

Sponsor: Melissa Pugliano-Mauro | Conditions: Carcinoma, Squamous Cell | Phase 1 | Status: RECRUITING